Radiat Oncol 2018 Mar 20

A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma.

Related Questions

What is your approach to SBRT to an entire kidney infiltrated with RCC?

I have treated a patient in this situation recently, and we did end up treating the entire kidney. One concern brought up in our peer review was possible malignant hypertension from fibrosing of the whole kidney. Prior to treatment, we did get a differential renal flow scan just to ensure the treate...

Would you offer RT to a large infiltrative renal metastasis in a patient with minimal other systemic disease?

2 Answers

Mednet Member

Radiation Oncology · Virginia Commonwealth University Medical Center

With modern treatment delivery techniques, there really are no longer any regions in the body in which a potentially therapeutic dose of radiation cannot be delivered, and durable local control can be achieved in locations where this was not possible in the past. Nevertheless, as the question implie...